Gene · 599
Papers4,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers. | Cancers (Basel) | 2023 | 37894324 | PubTator, text mining | PubMed |
| RNA modification in cardiovascular disease: implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37884527 | PubTator, text mining | PubMed |
| DNA nanoparticles targeting FOXO4 selectively eliminate cigarette smoke-induced senescent lung fibroblasts. | Nanoscale Adv | 2023 | 37881696 | PubTator, text mining | PubMed |
| Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients. | Commun Med (Lond) | 2023 | 37880389 | PubTator, text mining | PubMed |
| In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPER. | Sci Rep | 2023 | 37863936 | PubTator, text mining | PubMed |
| A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation. | EMBO Rep | 2023 | 37846472 | PubTator, text mining | PubMed |
| Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia. | Cancer Drug Resist | 2023 | 37842232 | PubTator, text mining | PubMed |
| Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal. | Cancers (Basel) | 2023 | 37835493 | PubTator, text mining | PubMed |
| Bioinformatic analysis of m6A "reader" YTH family in pan-cancer as a clinical prognosis biomarker. | Sci Rep | 2023 | 37833468 | PubTator, text mining | PubMed |
| Senescent Cells: Dual Implications on the Retinal Vascular System. | Cells | 2023 | 37830555 | PubTator, text mining | PubMed |
| Combined oncolytic virotherapy gold nanoparticles as synergistic immunotherapy agent in breast cancer control. | Sci Rep | 2023 | 37803068 | PubTator, text mining | PubMed |
| Small molecules targeting protein-protein interactions for cancer therapy. | Acta Pharm Sin B | 2023 | 37799384 | PubTator, text mining | PubMed |
| Recent advances in therapies for primary myelofibrosis. | Fac Rev | 2023 | 37771602 | PubTator, text mining | PubMed |
| Cellular senescence: a double-edged sword in cancer therapy. | Front Oncol | 2023 | 37771436 | PubTator, text mining | PubMed |
| Piper nigrum Extract Inhibits the Growth of Human Colorectal Cancer HT-29 Cells by Inducing p53-Mediated Apoptosis. | Pharmaceuticals (Basel) | 2023 | 37765133 | PubTator, text mining | PubMed |
| CircRNAs: A Promising Star for Treatment and Prognosis in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37762497 | PubTator, text mining | PubMed |
| Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases. | Int J Mol Sci | 2023 | 37761989 | PubTator, text mining | PubMed |
| Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities. | Biomedicines | 2023 | 37760929 | PubTator, text mining | PubMed |
| Cytocompatibility and Osteoinductive Properties of Collagen-Fibronectin Hydrogel Impregnated with siRNA Targeting Glycogen Synthase Kinase 3β: In Vitro Study. | Biomedicines | 2023 | 37760805 | PubTator, text mining | PubMed |
| Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress. | Cells | 2023 | 37759522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/599/papers?page=8